Regorafenib in Patients With Refractory Primary Bone Tumors
Clinical trial NCT05395741 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05395741
- Sponsor
- Institute of Mother and Child, Warsaw, Poland
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-28
- Primary completion
- 2025-09-12
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.